首页|调节性T细胞在结直肠癌免疫治疗中的意义

调节性T细胞在结直肠癌免疫治疗中的意义

Clinical significance of regulatory T cells in immunotherapy for colorectal cancer

扫码查看
肿瘤微环境(TME)中的免疫抑制会减弱抗肿瘤免疫,从而阻碍机体的保护性免疫监视并阻止癌症免疫疗法诱导的有效抗肿瘤免疫.多种机制参与了 TME 的免疫抑制,其中包括多个免疫位点(如 CTLA-4、PD-1 和LAG-3)和免疫抑制细胞.调节性 T(Treg)细胞是一类免疫抑制细胞,在抑制机体抗肿瘤免疫方面发挥着重要作用.TME中的 Treg 细胞与结直肠癌的不良预后密切相关.Treg 细胞被认为是结直肠癌免疫治疗中主要靶点之一.因此,阐明癌症患者的 Treg 细胞功能对于开发最佳的 Treg 细胞靶向免疫疗法至关重要.本文就TME中的Treg细胞的功能和表型以及靶向免疫疗法中可能的治疗策略进行综述.
Immunosuppression in the tumor microenvironment(TME)can weaken the anti-tumor immunity,thus hindering the protective immune surveillance and blocking the effective anti-tumor immunity induced by cancer immunotherapy.Multiple mechanisms are involved in the immunosuppression of TME,including the involvement of multiple immune sites(e.g.,cytotoxic T-lymphocyte antigen-4[CTLA-4],programmed cell death 1[PD-1]and lymphocyte-activation gene 3[LAG-3])and immunosuppressive cells.Regulatory T(Treg)cells are a type of immunosuppressive cells that play an important role in inhibiting the anti-tumor immunity.Treg cells in the TME are closely related to the poor prognosis of colorectal cancer.Treg cells are considered as one of the main targets in immunotherapy for colorectal cancer.Therefore,elucidating the biological functions of Treg cells in cancer patients are crucial for developing optimal Treg cell-targeted immunotherapy.Here,we describe the function and phenotype of Treg cells in the TME from the perspective of Treg cell targeted immunotherapy,thus providing new ideas for immunotherapy of colorectal cancer.

regulatory T cellstumor microenvironmentimmunotherapy

党利敏、马虎林

展开 >

010017 呼和浩特市,内蒙古自治区人民医院腹部肿瘤外科

内蒙古医科大学研究生学院

调节性T细胞 肿瘤微环境 免疫治疗

内蒙古自治区人民医院院内基金项目

2021YN23

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(2)
  • 60